Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

Clinical trial NCT01585194 · COMPLETED

Trial details

NCT number: NCT01585194
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Uveal Melanoma Stage IV Uveal Melanoma AJCC v7

Start date: 2012-11-29
Primary completion: 2019-12-02
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.